These emerging treatments, Tirzepatide , represent a groundbreaking advancement in addressing metabolic dysfunction and potentially related conditions . They all are grouped as GLP-1 receptor agonists , signifying they to emulate the body's GLP-1 peptide, stimulating insulin production and suppressing appetite . Although Semaglutide every functions